CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $634,587 | +33.3% | 7,180 | +23.8% | 0.00% | 0.0% |
| Q3 2022 | $476,000 | -59.6% | 5,801 | -26.3% | 0.00% | 0.0% |
| Q1 2022 | $1,179,000 | +180.0% | 7,868 | +164.8% | 0.00% | – |
| Q4 2021 | $421,000 | -14.8% | 2,971 | -20.9% | 0.00% | – |
| Q3 2021 | $494,000 | -7.3% | 3,758 | -4.3% | 0.00% | -100.0% |
| Q2 2021 | $533,000 | -44.9% | 3,926 | -46.3% | 0.00% | 0.0% |
| Q1 2021 | $968,000 | +22.5% | 7,306 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $790,000 | +1.3% | 7,062 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $780,000 | +87.1% | 7,006 | +61.9% | 0.00% | 0.0% |
| Q3 2019 | $417,000 | +56.8% | 4,328 | +39.5% | 0.00% | 0.0% |
| Q2 2019 | $266,000 | -90.2% | 3,102 | -90.5% | 0.00% | -80.0% |
| Q1 2019 | $2,727,000 | -34.9% | 32,774 | -49.8% | 0.01% | -37.5% |
| Q4 2018 | $4,187,000 | +211.3% | 65,227 | +207.1% | 0.01% | +300.0% |
| Q1 2018 | $1,345,000 | +320.3% | 21,238 | +193.0% | 0.00% | +100.0% |
| Q4 2016 | $320,000 | – | 7,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |